|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/155 | (2006.01) |
| A61K 45/06 | (2006.01) | ||
| A61K 38/26 | (2006.01) |
| (11) | Number of the document | 2324853 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09175876.3 |
| Date of filing the European patent application | 2009-11-13 | |
| (97) | Date of publication of the European application | 2011-05-25 |
| (45) | Date of publication and mention of the grant of the patent | 2015-08-26 |
| (46) | Date of publication of the claims translation | 2015-12-28 |
| (72) |
Silvestre, Louise, FR
Sert-Langeron, Caroline, FR
Zhou, Tianyue, US
|
| (73) |
Sanofi-Aventis Deutschland GmbH,
Brüningstra e 50, 65929 Frankfurt am Main,
DE
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Liksizenatidas kaip papildantis metforminą 2 tipo diabeto gydyme |
| Lixisenatide as add-on to metformin in the treatment of diabetes type 2 |
| Payment date | Validity (years) | Amount | |
| 2018-10-17 | 10 | 231.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2019-11-13 |